Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection Academic Article uri icon

Overview

MeSH Major

  • Cardiovascular Diseases
  • Cytomegalovirus Infections
  • Graft Rejection
  • Heart Transplantation
  • Muromegalovirus

abstract

  • Prolonged (val)ganciclovir plus CMVIG reduces viral levels, acute rejection, and allograft vascular disease, suggesting a role for chronic subclinical infection in the pathophysiology of the most common diseases affecting heart transplant recipients.

publication date

  • August 18, 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/01.tp.0000229039.87735.76

PubMed ID

  • 16906040

Additional Document Info

start page

  • 398

end page

  • 405

volume

  • 82

number

  • 3